Scopus BioPharma Inc.
SCPS
$0.0003
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -2.62M | -2.45M | -1.73M | -1.90M | -3.32M |
| Total Depreciation and Amortization | 300.00 | 200.00 | 200.00 | 300.00 | 600.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -234.20K | -151.70K | -26.90K | 83.60K | 95.00K |
| Change in Net Operating Assets | 1.84M | 1.84M | 1.34M | 963.10K | 348.40K |
| Cash from Operations | -1.01M | -759.90K | -421.90K | -851.70K | -2.88M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.00K | 899.50K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -79.70K | 1.12M | 241.90K | -- | -- |
| Cash from Financing | -44.70K | 2.02M | 241.90K | -- | -- |
| Foreign Exchange rate Adjustments | 14.50K | 17.30K | -6.30K | 6.00K | 57.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.04M | 1.28M | -186.20K | -845.60K | -2.82M |